Quick Takeaways
- Jason Ryan has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $14,971,290.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Jason Ryan
- Location
- Cambridge, MA
- Summary
- The estimated net worth of Jason Ryan is at least $14,971,290 dollars as of 27 Aug 2025. Jason Ryan is the Director of GeneDx Holdings Corp. and owns shares of GeneDx Holdings Corp. (WGS) stock worth about $14.97M.
- Signature
- /s/ Bridget Brown, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Jason Ryan and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: GeneDx Holdings Corp. ($14,971,290).
- Past-year value change for that position: -$4,995,801.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Jason Ryan
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| WGS, WGSWW | GeneDx Holdings Corp. | Director | $14,971,290 | -$4,995,801 | -25% | 27 Aug 2025 |
| OMIC | Singular Genomics Systems, Inc. | Director | $0 | 21 Feb 2025 | ||
| SLGC | SomaLogic, Inc. | Director | 05 Jan 2024 |
Insider Transactions Reported by Jason Ryan:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.